Browsing Over 249 Presentations
Sort By
Presentation Number
Biomarkers and translational research and precision medicine
5P - HER2DX risk-score in HER2-positive (HER2+) breast cancer following neoadjuvant and adjuvant anti-HER2-based treatment: an updated survival analysis (ID 225)
Presentation Number
5P
Speakers
- Olga Martinez Saez (Barcelona, Spain)
Authors
- Olga Martinez Saez (Barcelona, Spain)
- Fara Brasó-Maristany (Barcelona, Spain)
- Gaia Griguolo (Padova, Italy)
- Laia Pare Brunet (Barcelona, Spain)
- Maria Vittoria Dieci (Padova, Italy)
- Javier Cortes (Madrid and Barcelona, Spain)
- Antonio Llombart Cussac (Valencia, Spain)
- Guillermo Villacampa (Barcelona, Spain)
- Mercedes Marín-Aguilera (Barcelona, Spain)
- Maria Rey (Barcelona, Spain)
- Gerard Goberna (Barcelona, Spain)
- Montserrat Munoz (Barcelona, Spain)
- Ana Vivancos (Barcelona, Spain)
- Patricia Villagrasa Gonzalez (Barcelona, Spain)
- Joel Parker (Chapel Hill, United States of America)
- Pier Franco Conte (Padova, Italy)
- Aleix Prat (Barcelona, Spain)
- Tomas Pascual (Barcelona, Spain)
- Valentina Guarneri (Padova, Italy)
Presentation Topic
Biomarkers and translational research and precision medicine
Biomarkers and translational research and precision medicine
6P - Combined analysis of the HER2DX genomic tool in adjuvant APT and ATEMPT trials (ID 226)
Presentation Number
6P
Speakers
- Paolo Tarantino (Boston, MA, United States of America)
Authors
- Paolo Tarantino (Boston, MA, United States of America)
- Guillermo Villacampa (Barcelona, Spain)
- Noah Graham (Boston, United States of America)
- Adrienne G. Waks (Boston, MA, United States of America)
- Patricia Villagrasa Gonzalez (Barcelona, Spain)
- Fara Brasó-Maristany (Barcelona, Spain)
- Esther Sanfeliu Torres (Barcelona, Spain)
- Patricia Galván (Barcelona, Spain)
- Laia Pare Brunet (Barcelona, Spain)
- Michelle K. Demeo (Boston, United States of America)
- Ann H. Partridge (Boston, MA, United States of America)
- Harold J. Burstein (Boston, United States of America)
- Ian Krop (New Haven, United States of America)
- Nabihah Tayob (Boston, United States of America)
- Eric P. Winer (New Haven, United States of America)
- Aleix Prat (Barcelona, Spain)
- Sara M. Tolaney (Boston, MA, United States of America)
Presentation Topic
Biomarkers and translational research and precision medicine
Biomarkers and translational research and precision medicine
7P - Independent validation of HER2DX ERBB2 mRNA score to predict HER2-positive (HER2+), HER2-low and HER2-0 status in breast cancer (ID 227)
Presentation Number
7P
Speakers
- Esther Sanfeliu Torres (Barcelona, Spain)
Authors
- Esther Sanfeliu Torres (Barcelona, Spain)
- Guillermo Villacampa (Barcelona, Spain)
- Tomas Pascual (Barcelona, Spain)
- Ana Mafalda Antunes De Melo e Oliveira (Barcelona, Spain)
- Maria Jesus Vidal Losada (Barcelona, Spain)
- Meritxell Bellet Ezquerra (Barcelona, Spain)
- Blanca Gonzalez-Farre (Barcelona, Spain)
- Joan A. Puig-Butille (Barcelona, Spain)
- Pedro Jares (Barcelona, Spain)
- Sonia Pernas Simon (L'Hospitalet de Llobregat, Spain)
- Coralia Bueno Muiño (Alcorcon, Ma, Spain)
- Miguel Martin (Madrid, Spain)
- Paolo Tarantino (Boston, MA, United States of America)
- Adrienne G. Waks (Boston, MA, United States of America)
- Elizabeth A. Mittendorf (Boston, United States of America)
- Sara M. Tolaney (Boston, MA, United States of America)
- Javier Cortes (Madrid and Barcelona, Spain)
- Antonio Llombart Cussac (Valencia, Spain)
- Aleix Prat (Barcelona, Spain)
- Fara Brasó-Maristany (Barcelona, Spain)
Presentation Topic
Biomarkers and translational research and precision medicine
Biomarkers and translational research and precision medicine
8P - First decision impact study of HER2DX in patients (pts) with HER2-positive (HER2+) early breast cancer (ID 228)
Presentation Number
8P
Speakers
- Olga Martinez Saez (Barcelona, Spain)
Authors
- Olga Martinez Saez (Barcelona, Spain)
- Fara Brasó-Maristany (Barcelona, Spain)
- Mercedes Marín-Aguilera (Barcelona, Spain)
- Maria Jesus Vidal Losada (Barcelona, Spain)
- Barbara Adamo (Barcelona, Spain)
- Tomas Pascual (Barcelona, Spain)
- Francesco Schettini (Barcelona, Spain)
- Benedetta Conte (Barcelona, Spain)
- Nuria Chic (Barcelona, Spain)
- RAQUEL Gomez Bravo (Barcelona, Spain)
- Isabel Garcia Fructuoso (Barcelona, Spain)
- Elia Segui Solis (Barcelona, Spain)
- Patricia Galván (Barcelona, Spain)
- Eva Hernández-Illán (Barcelona, Spain)
- Pedro Jares (Barcelona, Spain)
- Joan A. Puig-Butille (Barcelona, Spain)
- Esther Sanfeliu Torres (Barcelona, Spain)
- Laia Pare Brunet (Barcelona, Spain)
- Patricia Villagrasa Gonzalez (Barcelona, Spain)
- Montserrat Munoz (Barcelona, Spain)
Presentation Topic
Biomarkers and translational research and precision medicine
Biomarkers and translational research and precision medicine
9P - Prognostic Value of Baseline Neutrophil/Lymphocyte Ratio in HER2-Positive Metastatic Breast Cancer: Exploratory analysis from the CLEOPATRA trial (ID 229)
Presentation Number
9P
Speakers
- Zhi Xiao (Changsha, China)
Authors
- Zhi Xiao (Changsha, China)
- Nianhua Ding (Changsha, China)
- Jian Pang (Changsha, China)
- Xuan Liu (Xiangtan, China)
- Xiongbin He (chenzhou, China)
- Wei Zhou (ZhuZhou, China)
- Haiqing Xie (chenzhou, China)
- Jianqi Feng (Huaihua, China)
- Guo Wang (Changsha, China)
- Jie Tang (Changsha, China)
- Jing Can (Changsha, China)
- Liying He (Changsha, China)
- Yingjian He (Peking, China)
- Shouman Wang (Changsha, China)
Presentation Topic
Biomarkers and translational research and precision medicine
Biomarkers and translational research and precision medicine
10P - HER2 loss and PAM50 dynamics after neoadjuvant therapy (NAT) in HER2 positive (HER2+) early breast cancer (BC) (ID 230)
Presentation Number
10P
Speakers
- Stefania Morganti (Boston, MA, United States of America)
Authors
- Stefania Morganti (Boston, MA, United States of America)
- Fara Brasó-Maristany (Barcelona, Spain)
- Maria Rey (Barcelona, Spain)
- Gerard Goberna (Barcelona, Spain)
- Tomas Pascual (Barcelona, Spain)
- Francesco Schettini (Barcelona, Spain)
- Benedetta Conte (Barcelona, Spain)
- RAQUEL Gomez Bravo (Barcelona, Spain)
- Isabel Garcia Fructuoso (Barcelona, Spain)
- Elia Segui Solis (Barcelona, Spain)
- Patricia Galván (Barcelona, Spain)
- Esther Sanfeliu Torres (Barcelona, Spain)
- Blanca Gonzalez-Farre (Barcelona, Spain)
- Maria Jesus Vidal Losada (Barcelona, Spain)
- Barbara Adamo (Barcelona, Spain)
- Montserrat Munoz (Barcelona, Spain)
- Nancy Lin (Boston, MA, United States of America)
- Sara M. Tolaney (Boston, MA, United States of America)
- Aleix Prat (Barcelona, Spain)
- Olga Martinez Saez (Barcelona, Spain)
Presentation Topic
Biomarkers and translational research and precision medicine
Biomarkers and translational research and precision medicine
11P - Independent validation of the HER2DX assay in HER2-positive (HER2+) breast cancer (BC) treated with neoadjuvant paclitaxel, trastuzumab and pertuzumab (THP): a correlative analysis from the BiOnHER study (ID 231)
Presentation Number
11P
Speakers
- Bartomeu Fullana Grimalt (Hospitalet de Llobregat, Spain)
Authors
- Bartomeu Fullana Grimalt (Hospitalet de Llobregat, Spain)
- Fara Brasó-Maristany (Barcelona, Spain)
- Nàdia Gómez (Hospitalet de Llobregat, Spain)
- Anna Petit (Hospitalet de Llobregat, Spain)
- Raul Ortega (Hospitalet de Llobregat, Spain)
- Maria Vicente (Hospitalet de Llobregat, Spain)
- Catalina Falo (L'Hospitalet de Llobregat, Spain)
- Agostina Stradella (L'Hospitalet de Llobregat, Spain)
- Silvia Vazquez (L'Hospitalet de Llobregat, Spain)
- Rafael Villanueva Vazquez (Hospitalet de Llobregat, Spain)
- María Jesús Pla (Hospitalet de Llobregat, Spain)
- Elvira Purqueras (Hospitalet de Llobregat, Spain)
- Monica Calaf (Hospitalet de Llobregat, Spain)
- Laia Pare Brunet (Barcelona, Spain)
- Mercedes Marín-Aguilera (Barcelona, Spain)
- Patricia Galván (Barcelona, Spain)
- Charles M. Perou (Chapel Hill, NC, United States of America)
- Patricia Villagrasa Gonzalez (Barcelona, Spain)
- Aleix Prat (Barcelona, Spain)
- Sonia Pernas Simon (L'Hospitalet de Llobregat, Spain)
Presentation Topic
Biomarkers and translational research and precision medicine
Biomarkers and translational research and precision medicine
12P - HER2DX in HER2-positive (HER2+) Inflammatory Breast Cancer (IBC): a correlative analysis from a phase II clinical trial (ID 232)
Presentation Number
12P
Speakers
- Adrienne G. Waks (Boston, MA, United States of America)
Authors
- Filipa Lynce (Boston, MA, United States of America)
- Fara Brasó-Maristany (Barcelona, Spain)
- Adrienne G. Waks (Boston, MA, United States of America)
- Patricia Villagrasa Gonzalez (Barcelona, Spain)
- Guillermo Villacampa (Barcelona, Spain)
- Esther Sanfeliu Torres (Barcelona, Spain)
- Patricia Galván (Barcelona, Spain)
- Laia Pare Brunet (Barcelona, Spain)
- Leilani Anderson (Boston, United States of America)
- Charles M. Perou (Chapel Hill, NC, United States of America)
- Joel Parker (Chapel Hill, United States of America)
- Ana Vivancos (Barcelona, Spain)
- Molly Dilullo (Boston, MA, United States of America)
- Sonia Pernas Simon (L'Hospitalet de Llobregat, Spain)
- Eric P. Winer (New Haven, United States of America)
- Beth Overmoyer (Boston, United States of America)
- Elizabeth A. Mittendorf (Boston, United States of America)
- Aleix Prat (Barcelona, Spain)
- Sara M. Tolaney (Boston, MA, United States of America)
Presentation Topic
Biomarkers and translational research and precision medicine
Biomarkers and translational research and precision medicine
13P - Analytical validation of HER2DX test for early-her2+ breast cancer (ID 233)
Presentation Number
13P
Speakers
- Esther Sanfeliu Torres (Barcelona, Spain)
Authors
- Esther Sanfeliu Torres (Barcelona, Spain)
- Mercedes Marín-Aguilera (Barcelona, Spain)
- Pedro Jares (Barcelona, Spain)
- Guillermo Villacampa (Barcelona, Spain)
- Eva Hernández-Illán (Barcelona, Spain)
- Blanca Gonzalez-Farre (Barcelona, Spain)
- Fara Brasó-Maristany (Barcelona, Spain)
- Patricia Galván (Barcelona, Spain)
- Oleguer Castillo (Barcelona, Spain)
- Paula Blasco (Barcelona, Spain)
- Valeria Sirenko (Barcelona, Spain)
- Ángela Aguirre (Barcelona, Spain)
- Joan A. Puig-Butille (Barcelona, Spain)
- Ana Vivancos (Barcelona, Spain)
- Judit Matito (Barcelona, Spain)
- Charles M. Perou (Chapel Hill, NC, United States of America)
- Patricia Villagrasa Gonzalez (Barcelona, Spain)
- Aleix Prat (Barcelona, Spain)
- Joel Parker (Chapel Hill, United States of America)
- Laia Pare Brunet (Barcelona, Spain)
Presentation Topic
Biomarkers and translational research and precision medicine
Biomarkers and translational research and precision medicine
14P - Comparison of single-cell ERBB2 mRNA expression levels with HER2 status by immunohistochemistry reveals heterogeneity of the HER2-low status (ID 234)
Presentation Number
14P
Speakers
- François Richard (Leuven, Belgium)
Authors
- François Richard (Leuven, Belgium)
- Tatjana Geukens (Leuven, Belgium)
- Hanne Vos (Leuven, Belgium)
- Ayse Bassez (Leuven, Belgium)
- Ha Linh Nguyen (Leuven, Belgium)
- Marion Maetens (Leuven, Belgium)
- Ling Wang (Leuven, Belgium)
- Ines Nevelsteen (Leuven, Belgium)
- Hans Wildiers (Leuven, Belgium)
- Patrick Neven (Leuven, Belgium)
- Kevin Punie (Leuven, Belgium)
- Ann Smeets (Leuven, Belgium)
- Diether Lambrechts (Leuven, Belgium)
- Giuseppe Floris (Leuven, Belgium)
- Christine Desmedt (Leuven, Belgium)
Presentation Topic
Biomarkers and translational research and precision medicine
Biomarkers and translational research and precision medicine
15P - Portraying HER2-positive breast cancer heterogeneity with spatial transcriptomics (ID 235)
Presentation Number
15P
Speakers
- Mattia Rediti (Brussels, Belgium)
Authors
- Mattia Rediti (Brussels, Belgium)
- Matteo Serra (Brussels, Belgium)
- Frédéric Lifrange (Liège, Belgium)
- Chiara Tommasi (Parma, Italy)
- Nicola Occelli (Brussels, Belgium)
- Xiaoxiao Wang (Brussels, Belgium)
- Delphine Vincent (Brussels, Belgium)
- Ghizlane Rouas (Brussels, Belgium)
- Ligia Craciun (Brussels, Belgium)
- Laurence Buisseret (Brussels, Belgium)
- Denis Larsimont (Brussels, Belgium)
- David Venet (Brussels, Belgium)
- Françoise Rothé (Brussels, Belgium)
- Christos Sotiriou (Brussels, Belgium)
Presentation Topic
Biomarkers and translational research and precision medicine
Biomarkers and translational research and precision medicine
16P - Monitoring response to neoadjuvant chemotherapy in TNBC using circulating tumor DNA (ID 236)
Presentation Number
16P
Speakers
- ANTHONY LUCCI (Houston, TX, United States of America)
Authors
- ANTHONY LUCCI (Houston, TX, United States of America)
- Sridevi Addanki (Houston, United States of America)
- Ekaterina Kalashnikova (San Carlos, CA, United States of America)
- Derrick Renner (Austin, TX, United States of America)
- Henry M. Kuerer (Houston, United States of America)
- Salyna Meas (Houston, United States of America)
- Vanessa N. Sarli (Houston, United States of America)
- Jason B. White (Houston, United States of America)
- GAIANE Rauch (Houston, TX, United States of America)
- Debu Tripathy (Houston, TX, United States of America)
- Banu K. Arun (Houston, TX, United States of America)
- Carlos H. Barcenas (Houston, United States of America)
- Clinton Yam (Houston, United States of America)
- Angel A. Rodriguez (San Carlos, CA, United States of America)
- Minetta C. Liu (San Carlos, CA, United States of America)
- Stacy L. Moulder (Indianapolis, IN, United States of America)
Presentation Topic
Biomarkers and translational research and precision medicine